21/12/2022
EudraVigilance is the centralized European database of suspected adverse reactions to medicines that are authorized or being studied in clinical trials in the European Economic Area (EEA). It is used by national competen
21/09/2022
The European Medicines Agency (EMA) and the Heads of Medicines Agencies (HMA) decided to harmonise EU position on interchangeability of biological medicines by issuing a joint statement confirming that biosimilar medicines approve
15/09/2022
The status of Responsible Pharmacist in a pharmaceutical company is specific to France and is regulated by the Public Health Code (CSP).In France, any company with at least one pharmaceutical establishment must be owned by a pharm
01/09/2022
Clinical trials in human medicines are studies carried out in human volunteers intended to investigate the safety or efficacy of one or more investigational medicines.Clinical trials can only be started after a compound has passed
23/08/2022
The continued availability of medicines is one of the most important priorities for EU authorities. Indeed, shortages or other problems with the availability of medicinal products create challenges for the medicine supply chain an